Ditchcarbon
  • Contact
  1. Organizations
  2. Curium SAS
Public Profile
Pharmaceutical Preparation Manufacturing
FR
updated 23 days ago

Curium SAS

Company website

Curium SAS, a leading player in the nuclear medicine industry, is headquartered in France and operates extensively across Europe and North America. Founded in 2017, the company has quickly established itself as a key provider of radiopharmaceuticals, focusing on innovative solutions for cancer diagnosis and treatment. Curium's core offerings include a range of diagnostic imaging agents and therapeutic products, distinguished by their high quality and reliability. The company is committed to advancing patient care through its cutting-edge technologies and extensive expertise in the field. With a strong market position, Curium SAS has achieved significant milestones, including the integration of several prominent radiopharmaceutical businesses, enhancing its portfolio and global reach. As a trusted partner in healthcare, Curium continues to lead the way in the development of life-saving nuclear medicine solutions.

DitchCarbon Score

How does Curium SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Curium SAS's score of 26 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

48%

Let us know if this data was useful to you

Curium SAS's reported carbon emissions

Curium SAS, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Curium SAS may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is challenging to assess Curium SAS's position relative to its peers in terms of climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Curium SAS's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Curium SAS is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Curium SAS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

GE Healthcare Inc.

US
•
Health and social work services (85)
Updated 25 days ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Bayer

DE
•
Chemicals nec
Updated 4 days ago

Bracco Diagnostics Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Jubilant Drax Image Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251008.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy